Martin A. Lehr bought $15k of CNTX
Chief Executive Officer at Context Therapeutics Inc.. 20,000 shares at an average of $0.74, traded Dec 16, 2022, filed Dec 19, 2022.
Score components
- +25RoleCEO
- 0Trade size$15k at market
- +3Relative to holdingsHoldings up 19%
- +8Price context77% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001842952-22-000112, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2022 | POpen-market purchase Common Stock | +20,000 | $0.74 | $15k | 122,583 | Dec 19, 2022 |
Related signals
Other insiders at Context Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 52Moderate | Context Therapeutics Inc. | Jennifer Lynn Minai-Azary Chief Financial Officer | $25k 40,010 shares | +100% | |
| 40Moderate | Context Therapeutics Inc. | Alex C. Levit Chief Legal Officer, Corp. Sec | $12k 20,000 shares | +222% | |
| 51Moderate | Context Therapeutics Inc. | Martin A. Lehr Chief Executive Officer | $70k 100,000 shares | +12% | |
| 55Moderate | Context Therapeutics Inc. | Jennifer Lynn Minai-Azary Chief Financial Officer | $19k 25,000 shares | +167% | |
| 58Moderate | Context Therapeutics Inc. | Alex C. Levit Chief Legal Officer, Corp. Sec | $5,095 6,000 shares | +200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.